J. Lavoie

发表

Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22)

D. Horsman, H. Bruyèrè, M. Copland, 2002, European journal of haematology.

Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term results

R. Gascoyne, J. Connors, R. Brinkman, 2008, Bone Marrow Transplantation.

Allogeneic haematopoietic stem‐cell transplantation for relapsed and refractory aggressive histology non‐Hodgkin lymphoma *

R. Gascoyne, J. Connors, D. Hogge, 2005, British journal of haematology.

Long‐term disease‐free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation

R. Gascoyne, J. Connors, D. Hogge, 2004, British journal of haematology.

Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis

D. Hogge, S. Nantel, S. Nantel, 2003, Bone Marrow Transplantation.

Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels.

R. Brinkman, M. Power, D. Hogge, 2009, Leukemia research.

Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remission

M. Crump, A. Keating, Vikas Gupta, 2005, Leukemia & lymphoma.

Correlation between karyotype and quantitative immunophenotype in acute myelogenous leukemia with t(8;21)

D. Horsman, H. Khoury, D. Hogge, 2004, Modern Pathology.

Autologous Stem Cell Transplantation Is Superior to Myeloablative Allogeneic SCT as a Salvage Therapy for Patients with Refractory/Relapsed Transformed Lymphoma

R. Gascoyne, J. Connors, R. Brinkman, 2008 .

Prior Rituximab Reduces Relapse and Improves Survival Following High Dose Chemotherapy and Stem Cell Transplantation for Relapsed Composite Low and Intermediate Grade (Including Transformed) Lymphoma.

R. Gascoyne, J. Connors, R. Brinkman, 2006 .

Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia.

S. Nantel, D. Forrest, K. Song, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease

J. Lipton, S. Nantel, S. Nantel, 2005, Bone Marrow Transplantation.

Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.

J. Kuruvilla, D. Hogge, Clayton A. Smith, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Characteristics and outcome of patients developing endocarditis following hematopoietic stem cell transplantation

J. Kuruvilla, D. Hogge, S. Nantel, 2004, Bone Marrow Transplantation.

Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens

D. Hogge, S. Nantel, D. Forrest, 2010, Bone Marrow Transplantation.